Trachelospermi Caulis Extract Composition for the Treatment and Prevention of Inflammatory Diseases
    3.
    发明申请
    Trachelospermi Caulis Extract Composition for the Treatment and Prevention of Inflammatory Diseases 审中-公开
    用于治疗和预防炎症疾病的气管切片提取物组合物

    公开(公告)号:US20090285913A1

    公开(公告)日:2009-11-19

    申请号:US12307091

    申请日:2007-07-03

    IPC分类号: A61K36/24 A61P29/00

    摘要: The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory diseases comprising The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory diseases comprising Trachelospermi caulis extract as an active ingredient. More particularly, the pharmaceutical composition of the present invention is characterized in that it is standardized and formulated so that the arctiin is contained in the Trachelospermi caulis extract within a predetermined range to exhibit excellent inhibitory effects on pains, acute inflammation, acute edema, production of iNOS, and TNF-Yá, activation of the enzymes of MAP kinases and NFYêB, thus effective in the prevention and treatment of inflammatory diseases such as arthritis.

    摘要翻译: 本发明涉及用于预防和治疗炎症性疾病的药物组合物,其包含本发明涉及用于预防和治疗包括拔丝菌提取物作为活性成分的炎性疾病的药物组合物。 更具体地说,本发明的药物组合物的特征在于其标准化和配制,使得在预定范围内含有三氯乙酸提取物中的arctiin显示出优异的对疼痛,急性炎症,急性水肿,急性水肿的产生 iNOS和TNF-Ya,MAP激酶和NFYêB的酶的活化,因此有效预防和治疗炎性疾病如关节炎。